Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.

This study applies mixture modelling to examine age-specific immunity to varicella zoster virus (VZV) infection in Norway based on the first large-scale serological study in the general population. We estimated the seropositive proportions at different ages and calculated the underlying force of inf...

Full description

Bibliographic Details
Main Authors: Emanuele Del Fava, Grazina Rimseliene, Elmira Flem, Birgitte Freiesleben de Blasio, Gianpaolo Scalia Tomba, Piero Manfredi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5045180?pdf=render
id doaj-f5c0b8a91555411b8b98fee08d1730be
record_format Article
spelling doaj-f5c0b8a91555411b8b98fee08d1730be2020-11-25T02:15:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016363610.1371/journal.pone.0163636Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Emanuele Del FavaGrazina RimselieneElmira FlemBirgitte Freiesleben de BlasioGianpaolo Scalia TombaPiero ManfrediThis study applies mixture modelling to examine age-specific immunity to varicella zoster virus (VZV) infection in Norway based on the first large-scale serological study in the general population. We estimated the seropositive proportions at different ages and calculated the underlying force of infection by using a sample of 2103 residual sera obtained from patients seeking primary and hospital care. A rapid increase in the VZV-associated immunity is observed in the first years of life with 63% of children being immune by age 5. The increase in the immunity levels slows down thereafter, with a large proportion of adults still susceptible by age 20 (around 14.5%), thus at risk of serious sequelae of varicella infection. The corresponding force of infection peaks during the preschool period, subsequently declines to a minimum between ages 10 and 20 years, and afterwards moderately increases to reach a plateau lasting throughout the childbearing period. In comparison with the traditional cut-off approach, mixture modelling used the whole data without producing any inconclusive cases, led to an unbiased classification of individuals between susceptible and immune, and provided a smoother immune profile by age. These findings represent an important step towards any decision about the introduction of varicella vaccination in Norway, as they are a primary input for mathematical transmission models aimed at evaluating potential vaccination scenarios.http://europepmc.org/articles/PMC5045180?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Emanuele Del Fava
Grazina Rimseliene
Elmira Flem
Birgitte Freiesleben de Blasio
Gianpaolo Scalia Tomba
Piero Manfredi
spellingShingle Emanuele Del Fava
Grazina Rimseliene
Elmira Flem
Birgitte Freiesleben de Blasio
Gianpaolo Scalia Tomba
Piero Manfredi
Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
PLoS ONE
author_facet Emanuele Del Fava
Grazina Rimseliene
Elmira Flem
Birgitte Freiesleben de Blasio
Gianpaolo Scalia Tomba
Piero Manfredi
author_sort Emanuele Del Fava
title Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
title_short Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
title_full Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
title_fullStr Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
title_full_unstemmed Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
title_sort estimating age-specific immunity and force of infection of varicella zoster virus in norway using mixture models.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description This study applies mixture modelling to examine age-specific immunity to varicella zoster virus (VZV) infection in Norway based on the first large-scale serological study in the general population. We estimated the seropositive proportions at different ages and calculated the underlying force of infection by using a sample of 2103 residual sera obtained from patients seeking primary and hospital care. A rapid increase in the VZV-associated immunity is observed in the first years of life with 63% of children being immune by age 5. The increase in the immunity levels slows down thereafter, with a large proportion of adults still susceptible by age 20 (around 14.5%), thus at risk of serious sequelae of varicella infection. The corresponding force of infection peaks during the preschool period, subsequently declines to a minimum between ages 10 and 20 years, and afterwards moderately increases to reach a plateau lasting throughout the childbearing period. In comparison with the traditional cut-off approach, mixture modelling used the whole data without producing any inconclusive cases, led to an unbiased classification of individuals between susceptible and immune, and provided a smoother immune profile by age. These findings represent an important step towards any decision about the introduction of varicella vaccination in Norway, as they are a primary input for mathematical transmission models aimed at evaluating potential vaccination scenarios.
url http://europepmc.org/articles/PMC5045180?pdf=render
work_keys_str_mv AT emanueledelfava estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
AT grazinarimseliene estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
AT elmiraflem estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
AT birgittefreieslebendeblasio estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
AT gianpaoloscaliatomba estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
AT pieromanfredi estimatingagespecificimmunityandforceofinfectionofvaricellazostervirusinnorwayusingmixturemodels
_version_ 1724896387965911040